Corcept Therapeutics
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$26.5M
Doctors Paid
20,973
Transactions
112,910
2024 Total
$4.2M
Payment Breakdown by Category
Research$13.3M (50.3%)
Food & Beverage$2.6M (10.0%)
Consulting$2.6M (9.9%)
Travel$1.5M (5.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $13.3M | 2,168 | 50.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $4.7M | 2,168 | 17.7% |
| Food and Beverage | $2.6M | 102,336 | 10.0% |
| Consulting Fee | $2.6M | 1,135 | 9.9% |
| Travel and Lodging | $1.5M | 3,875 | 5.8% |
| Honoraria | $1.4M | 560 | 5.4% |
| Grant | $152,052 | 21 | 0.6% |
| Space rental or facility fees (teaching hospital only) | $77,030 | 35 | 0.3% |
| Education | $13,491 | 605 | 0.1% |
| Compensation for serving as faculty or as a speaker for a medical education program | $7,930 | 6 | 0.0% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $3,500 | 1 | 0.0% |
Payments by Type
Research
$13.3M
2,165 transactions
General
$13.2M
110,742 transactions
Ownership
$0
3 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| CORT125134-552 | $3.3M | 0 | 210 |
| CORT125134-550 | $2.9M | 0 | 71 |
| Study 550 | $2.5M | 0 | 63 |
| CORT125134-455 | $1.1M | 0 | 441 |
| CORT125281-601 | $858,185 | 0 | 171 |
| CORT118335-876 | $476,204 | 0 | 153 |
| CORT125134-452 | $383,402 | 0 | 107 |
| Study 500 | $224,230 | 0 | 19 |
| Study 451 | $197,382 | 0 | 27 |
| Study 700 | $174,731 | 0 | 11 |
| CORT125134-456 | $165,233 | 0 | 56 |
| CORT118335-877 | $132,430 | 0 | 42 |
| C1073-500 Phase 1 Study of Mifepristone in Combination with Eribulin in Patients with Locally AdvancedMetastatic Breast Cancer or Other Specified Solid Tumors, with a Dose Expansion Cohort in Patients with Triple Negative Breast Cancer | $130,132 | 0 | 5 |
| CORT125134-551 | $124,841 | 0 | 4 |
| CORT125134-553 | $85,048 | 0 | 19 |
| CORT125134-451 Cushing's Syndrome | $84,948 | 0 | 20 |
| FKBP5-700 | $73,069 | 0 | 5 |
| CORT125134-451 | $71,146 | 0 | 16 |
| MONARCH STUDY 862 | $67,174 | 33 | 310 |
| Study 601 | $63,315 | 0 | 10 |
| Study 860 | $35,700 | 0 | 2 |
| CATALYST | $33,568 | 22 | 167 |
| Study 455 | $28,372 | 16 | 126 |
| C1073-38 | $26,769 | 0 | 1 |
| CORT 125134-451 | $21,623 | 0 | 2 |
| C1073-500 | $13,964 | 0 | 2 |
| Phase 2 Study of the Safety and Efficacy of CORT125134 in the Treatment of Endogenous Cushing's Syndrome | $12,520 | 0 | 1 |
| Study 876 | $12,095 | 10 | 69 |
| CORT FKBP5-700 | $11,277 | 0 | 1 |
| STOMP-CSC | $7,500 | 0 | 1 |
Payments by Medical Specialty
Top Paid Doctors — Page 2
| Doctor | Specialty | Location | Total | 2024 |
|---|---|---|---|---|
| Fadi Al-Khayer, Md, MD | Endocrinology, Diabetes & Metabolism | Storrs, CT | $117,708 | $0 |
| Lance Sloan, Md, MD | Nephrology | Lufkin, TX | $114,104 | $0 |
| Brandi Addison, D.o, D.O | Endocrinology, Diabetes & Metabolism | Corpus Christi, TX | $108,166 | $0 |
| Ilja Hulinsky, Md Phd, MD PHD | Endocrinology, Diabetes & Metabolism | West Haven, CT | $100,265 | $0 |
| Leila Chaychi, Md, MD | Internal Medicine | San Carlos, CA | $96,558 | $0 |
| Dr. Lashelle Barmore, D.o, D.O | Family Medicine | Birmingham, AL | $96,166 | $0 |
| Lewis Blevins, Md, MD | Endocrinology, Diabetes & Metabolism | San Francisco, CA | $95,136 | $0 |
| Dr. Terri Jerkins, M.d, M.D | Endocrinology, Diabetes & Metabolism | Nashville, TN | $91,301 | $0 |
| Dr. Anthony Heaney, M.d, M.D | Endocrinology, Diabetes & Metabolism | Los Angeles, CA | $90,749 | $0 |
| Richard Auchus, Md, MD | Endocrinology, Diabetes & Metabolism | Ann Arbor, MI | $88,848 | $0 |
| Dr. Eugenio Angueira-Serrano, Md, MD | Endocrinology, Diabetes & Metabolism | Miami, FL | $87,925 | $0 |
| Dr. Isaiah Pittman, Md, MD | Endocrinology, Diabetes & Metabolism | Terre Haute, IN | $87,741 | $0 |
| Dr. Alan Marcus, M.d, M.D | Endocrinology, Diabetes & Metabolism | Laguna Hills, CA | $84,112 | $0 |
| Matthew Draelos, Md, MD | Endocrinology, Diabetes & Metabolism | Edmond, OK | $81,900 | $0 |
| Jawaad Khokhar, M.d, M.D | Internal Medicine | Glen Burnie, MD | $78,600 | $0 |
| Dr. Sandi-Jo Galati, M.d, M.D | Endocrinology, Diabetes & Metabolism | Trumbull, CT | $77,479 | $0 |
| Dr. Delali Blavo, Do, DO | Endocrinology, Diabetes & Metabolism | Southaven, MS | $77,054 | $0 |
| Dr. Kevin Yuen, Mbchb, Md, Frcp(Uk), MBCHB, MD, FRCP(UK) | Endocrinology, Diabetes & Metabolism | Phoenix, AZ | $73,851 | $0 |
| Shahid Aziz, M.d, M.D | Internal Medicine | San Antonio, TX | $72,110 | $0 |
| Firas Akhrass, Md, MD | Endocrinology, Diabetes & Metabolism | San Antonio, TX | $68,730 | $0 |
| Dr. Megan Wood, M.d, M.D | Internal Medicine | St. Louis, MO | $68,645 | $0 |
| Tamer Yacoub, M.d, M.D | Endocrinology, Diabetes & Metabolism | Fall River, MA | $63,827 | $0 |
| Amy Burmesch, Pa, PA | Physician Assistant | Menomonee Falls, WI | $62,878 | $0 |
| John Parker, M.d, M.D | Endocrinology, Diabetes & Metabolism | Wilmington, NC | $59,348 | $0 |
| Dr. James Suliburk, M.d, M.D | Surgery | Houston, TX | $58,798 | $0 |
About Corcept Therapeutics
Corcept Therapeutics has made $26.5M in payments to 20,973 healthcare providers, recorded across 112,910 transactions in the CMS Open Payments database. In 2024, the company paid $4.2M. The top product by payment volume is Korlym ($17.3M).
Payments were distributed across 184 medical specialties. The top specialty by payment amount is Endocrinology, Diabetes & Metabolism ($7.3M to 2,656 doctors).
Payment categories include: Food & Beverage ($2.6M), Consulting ($2.6M), Research ($13.3M), Travel & Lodging ($1.5M).
Corcept Therapeutics is associated with 1 products in the CMS Open Payments database.